1. Evaluation of the Effect of Dibornol on the Level of DNA Damage in the DNA Comet Test In Vivo.
- Author
-
Borovskaya TG, Vychuzhanina AV, Schemerova YA, Stremlina LA, Chukicheva IY, Kuchin AV, Goldberg VE, and Dygai AM
- Subjects
- Animals, Male, Mice, Rats, Liver drug effects, Kidney drug effects, Mice, Inbred C57BL, Bone Marrow drug effects, Camphanes pharmacology, Rectum drug effects, Rectum pathology, DNA Damage drug effects, Comet Assay methods, Rats, Wistar, Doxorubicin pharmacology, Doxorubicin toxicity, Methotrexate pharmacology, Methotrexate toxicity, Testis drug effects
- Abstract
In male C57BL/6 mice (8-12 weeks) and male Wistar rats (12 weeks), the effect of dibornol (2,6-diisobornyl-4-methylphenol) on the level of spontaneous DNA damage in cells of the bone marrow, liver, kidneys, and rectum of mice (series I) and genotoxic effects in rat testicular cells after administration of cytostatic drugs with different mechanisms of action (series II) were studied using the DNA comet assay. In series I, dibornol was intragastrically administered to mice once at doses of 200, 400, and 2000 mg/kg; in series II, dibornol was intragastrically administered to rats at a dose of 10 mg/kg for 5 days before and 5 days after the cytostatic treatment (methotrexate, doxorubicin). It was found that dibornol in all studied doses did not produce the genotoxic (carcinogenic) effect and reduced the level of spontaneous DNA damage in the bone marrow. After combined administration of cytostatic drugs (doxorubicin, methotrexate) and dibornol, the level of DNA breaks was reduced to 38.5 and 49% of the control, respectively., (© 2024. Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF